Powered by

Fennec Pharmaceuticals tumbles 6.7% on slipping relative strength Wednesday January 15, 2020 17:00 EST

Jan 15, 2020 - News Bites Canadian Markets
Financial Results


Fennec Pharmaceuticals Inc. (TSX:FRX), Canada's 11th largest Biotechnology company by market cap, has tumbled 61.0c (6.7%) from its previous trading session to close at CAD8.46. Compared with the S&P/TSX 60 Index which rose 3.6 points (0.3%) in the day, the relative price change was -7.1%. The volume was 0.01 times the average daily trading volume of 41,416 shares. In the Canadian market, Fennec Pharmaceuticals' stock's relative price strength percentile is slip...